GFH018
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GFH018, covering 2024-03-01 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC [Phase 2]